You can find the annual or quarterly income statement of LENZ Therapeutics Inc here for insights into the performance and operational efficiency of LENZ Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

--12.50M

--5.00M

----

Revenue

--12.50M

--5.00M

----

Operating expenses

142.46%31.39M

52.29%21.86M

5.24%16.93M

4.27%15.22M

-5.36%12.95M

-31.54%14.35M

-32.59%16.09M

-45.42%14.60M

-47.70%13.68M

-21.71%20.96M

-8.06%23.87M

41.24%26.75M

79.11%26.15M

52.72%26.78M

177.09%25.96M

--18.94M

287.94%14.60M

1257.04%17.53M

7642.15%9.37M

--3.76M

--1.29M

--121.00K

R&D expenses

-41.23%3.79M

30.47%9.06M

-44.79%5.82M

--5.87M

170.60%6.45M

-48.59%6.95M

-35.13%10.54M

-100.00%0.00

-86.97%2.38M

-24.01%13.51M

-10.97%16.24M

64.77%18.46M

110.78%18.30M

40.34%17.78M

239.33%18.25M

--11.21M

275.89%8.68M

2894.56%12.67M

--5.38M

--2.31M

--423.00K

--0.00

Depreciation, depletion, and amortization

1150.00%125.00K

5.56%19.00K

620.00%36.00K

-82.39%25.00K

-98.75%10.00K

-97.88%18.00K

-99.29%5.00K

-79.71%142.00K

14.29%800.00K

41.50%849.00K

59.09%700.00K

112.12%700.00K

250.00%700.00K

417.24%600.00K

340.00%440.00K

--330.00K

354.55%200.00K

11500.00%116.00K

--100.00K

--44.00K

--1.00K

--0.00

Other operating expenses

----

--1.00K

----

Operating profit

-45.90%-18.89M

-17.45%-16.86M

-5.24%-16.93M

-4.27%-15.22M

5.36%-12.95M

31.54%-14.35M

32.59%-16.09M

45.42%-14.60M

47.70%-13.68M

21.71%-20.96M

8.06%-23.87M

-41.24%-26.75M

-79.11%-26.15M

-52.72%-26.78M

-177.09%-25.96M

---18.94M

-287.94%-14.60M

-1257.04%-17.53M

-7642.15%-9.37M

---3.76M

---1.29M

---121.00K

Net non-operating interest income (expenses)

Non-operating interest income

-19.55%2.20M

-8.81%2.25M

194.80%2.32M

--2.57M

--2.74M

--2.46M

--788.00K

----

Non-operating interest expense

----

--0.00

-100.00%0.00

--0.00

--20.00K

Special income (expenses)

----

---10.95M

---11.35M

---36.90M

---2.58M

----

- Gains from disposal of fixed assets

----

--0.00

---300.00K

---71.00K

----

Other non-operating income (expenses)

-133.33%-14.00K

-87.83%199.00K

99.18%-11.00K

-89.33%8.00K

98.55%-6.00K

--1.64M

---1.35M

-96.51%75.00K

-128.06%-413.00K

----

21420.00%2.15M

14620.00%1.47M

20900.00%840.00K

101.19%123.00K

--10.00K

-97.37%10.00K

--4.00K

---10.34M

--380.00K

--0.00

Income before tax

-63.49%-16.70M

-40.55%-14.41M

12.19%-14.62M

44.80%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

---18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---3.38M

---1.31M

---141.00K

Income tax

--0.00

--500.00K

----

--1.00K

----

Income after tax

-63.49%-16.70M

-45.43%-14.91M

12.19%-14.62M

44.80%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

---18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---3.38M

---1.31M

---141.00K

Net income from continuous operations

-63.49%-16.70M

-45.43%-14.91M

12.19%-14.62M

44.79%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

---18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---3.38M

---1.31M

---141.00K

Other net gains and losses

----

---1.00K

----

Net income attributable to controlling interests

-63.49%-16.70M

-45.43%-14.91M

12.19%-14.62M

44.79%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

---18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---3.38M

---1.31M

---141.00K

Net income attributable to common shareholders

-63.49%-16.70M

-45.43%-14.91M

12.19%-14.62M

44.79%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

---18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---3.38M

---1.31M

---141.00K

Basic earnings per share

-55.65%-0.59

-32.63%-0.53

84.95%-0.53

83.44%-0.46

86.32%-0.38

94.13%-0.40

-17.67%-3.53

10.21%-2.77

12.17%-2.75

-105.11%-6.82

10.44%-3.00

-25.17%-3.09

-61.68%-3.13

-51.77%-3.33

-40.97%-3.35

---2.47

-374.55%-1.94

-1286.19%-2.19

-13865.02%-2.38

---0.41

---0.16

---0.02

Diluted earnings per share

-55.65%-0.59

-32.63%-0.53

84.95%-0.53

83.44%-0.46

86.32%-0.38

94.13%-0.40

-17.67%-3.53

10.21%-2.77

12.17%-2.75

-105.11%-6.82

10.44%-3.00

-25.17%-3.09

-61.68%-3.13

-51.77%-3.33

-40.97%-3.35

---2.47

-374.55%-1.94

-1286.19%-2.19

-13865.02%-2.38

---0.41

---0.16

---0.02

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

